Brooke Thomson, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 240 Cecily Dr, Fortson, GA 31808 Phone: 706-662-8781 |
News Archive
Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXAâ„¢ (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
Idaho Technology's patent portfolio continues to grow as the U.S. Patent and Trademark Office granted the company U.S. Patent No. 7,582,429 relating to methods of performing genetic analysis in the presence of a double-stranded nucleic acid binding dye.
Researchers at the University of Granada, Spain, have designed a new computing system that determines the age and sex of a corpse with a reliability of 95%. This system is based on free software called Image and a free DICOM displayer called K-Pacs.
Curcumin is found in the spice turmeric has been linked to a range of health benefits. Studies have already shown that it can beat cancer cells grown in a laboratory and benefits have been suggested in stroke and dementia patients as well. Cucurmin, which acts as an antioxidant and has anti-inflammatory properties, has traditionally been used as an alternative remedy for liver disease, digestive disorders, acne and a range of allergies. Some studies have shown it may slow the spread of cancer, boost the effectiveness of chemotherapy and protect healthy cells from the effects of radiotherapy.
It is almost axiomatic in medicine that the study of rare disorders informs the understanding of more common, widespread ailments.
› Verified 2 days ago